COVID-19 Crisis: Why Now is the Time to Invest in Glycemic Management
In the midst of the COVID-19 pandemic, emerging data suggests that glycemic control for patients with and without a previous diagnosis of diabetes is a critical component for managing the care of critically ill patients.
In this executive summary, you'll learn:
- The striking mortality results of recent COVID-19 research about patient outcomes related to hyperglycemia
- How hyperglycemia in COVID-19 patients impacted length of stay
- Best practice for inpatient glycemic management and what you can do now to improve glycemic management for your patients
Please fill out the form to download the whitepaper.